336 related articles for article (PubMed ID: 18591934)
1. Recruitment of adenomatous polyposis coli and beta-catenin to axin-puncta.
Faux MC; Coates JL; Catimel B; Cody S; Clayton AH; Layton MJ; Burgess AW
Oncogene; 2008 Oct; 27(44):5808-20. PubMed ID: 18591934
[TBL] [Abstract][Full Text] [Related]
2. Axin-independent phosphorylation of APC controls beta-catenin signaling via cytoplasmic retention of beta-catenin.
Seo E; Jho EH
Biochem Biophys Res Commun; 2007 May; 357(1):81-6. PubMed ID: 17418091
[TBL] [Abstract][Full Text] [Related]
3. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
4. The adenomatous polyposis coli protein (APC) exists in two distinct soluble complexes with different functions.
Penman GA; Leung L; Näthke IS
J Cell Sci; 2005 Oct; 118(Pt 20):4741-50. PubMed ID: 16188939
[TBL] [Abstract][Full Text] [Related]
5. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention.
Krieghoff E; Behrens J; Mayr B
J Cell Sci; 2006 Apr; 119(Pt 7):1453-63. PubMed ID: 16554443
[TBL] [Abstract][Full Text] [Related]
6. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
Kohler EM; Brauburger K; Behrens J; Schneikert J
Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
[TBL] [Abstract][Full Text] [Related]
8. Intracellular shuttling of a Drosophila APC tumour suppressor homolog.
Cliffe A; Mieszczanek J; Bienz M
BMC Cell Biol; 2004 Sep; 5():37. PubMed ID: 15458577
[TBL] [Abstract][Full Text] [Related]
9. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
[TBL] [Abstract][Full Text] [Related]
10. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation.
Hildesheim J; Belova GI; Tyner SD; Zhou X; Vardanian L; Fornace AJ
Oncogene; 2004 Mar; 23(10):1829-37. PubMed ID: 14647429
[TBL] [Abstract][Full Text] [Related]
11. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins.
Liu X; Rubin JS; Kimmel AR
Curr Biol; 2005 Nov; 15(22):1989-97. PubMed ID: 16303557
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
[TBL] [Abstract][Full Text] [Related]
14. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
15. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
16. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
Schneikert J; Ruppert JG; Behrens J; Wenzel EM
PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
[TBL] [Abstract][Full Text] [Related]
17. Examination of actin and microtubule dependent APC localisations in living mammalian cells.
Langford KJ; Askham JM; Lee T; Adams M; Morrison EE
BMC Cell Biol; 2006 Jan; 7():3. PubMed ID: 16423286
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
Hart MJ; de los Santos R; Albert IN; Rubinfeld B; Polakis P
Curr Biol; 1998 May; 8(10):573-81. PubMed ID: 9601641
[TBL] [Abstract][Full Text] [Related]
20. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
